BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2009
View Archived Issues
Johnson & Johnson reports third quarter 2009 results
Read More
BIBW-2948 not well tolerated in 4-week chronic obstructive pulmonary disease study
Read More
ADC-4022 given with budesonide protects lung function in COPD patients
Read More
Alimera Sciences completes 2-year patient follow-up for phase III Iluvien trial in DME
Read More
Provectus expands compassionate use program of PV-10 to cancer patients in U.S.
Read More
Pfizer completes acquisition of Wyeth
Read More
ZyStor Therapeutics cleared by FDA to start phase I trial of ZC-701 in Pompe disease
Read More
FDA recommends approval of Acorda Therapeutics' Fampridine-SR for MS
Read More
CSC and FSMA complete pre-IND meeting with FDA for stem cell-derived therapy for SMA
Read More
Moxaverine increases ocular blood flow in macular degeneration, glaucoma patients
Read More
Medarex releases full phase II results with MDX-100 in rheumatoid arthritis
Read More
Selective glucocorticoid receptor modulator has less effect on bone biomarkers
Read More
Anti-Fas IgM monoclonal antibody ARG-098 decreases rheumatoid arthritis activity
Read More
A-940894 shows potent in vivo/in vitro anti-inflammatory activity
Read More
CB1 receptor antagonists reported by sanofi-aventis for the treatment of diabetes
Read More
Cancer Research Technology claims Chk1 inhibitors for the treatment of cancer
Read More
Novel anti-tuberculosis compounds described by French scientists
Read More
FDA approves Merck & Co.'s Gardasil for prevention of genital warts in males
Read More
Cenomed BioSciences presents anti-emetic candidate devoid of anxiogenic effects
Read More
Immunomedics reports results for UCB's new SLE candidate, epratuzumab
Read More
Ono obtains approval in Japan for anti-emetic drug, Emend
Read More
NexMed provides update on antifungal agent NM-100060
Read More
Cervarix approval in Japan for prevention of cervical cancer caused by HPV
Read More
Soligenix initiates confirmatory phase III orBec trial in acute gastrointestinal GVHD
Read More
Prograf approved in Japan for the additional indication of myasthenia gravis
Read More